Skip to content

Clinical trials

Carcinoma, Merkel Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20193
20202
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
British Columbia Cancer Agency1
Incyte Corporation1
Kartos Therapeutics, Inc.1
Marengo Therapeutics, Inc.1
Medicenna Therapeutics, Inc.1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Ocellaris Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell11
Neoplasms5
Small Cell Lung Carcinoma5
Stomach Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Uterine Cervical Neoplasms4
Carcinoma, Hepatocellular3
Carcinoma, Renal Cell3
Colorectal Neoplasms3
Endometrial Neoplasms3

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.